医学
宫颈癌
接种疫苗
人乳头瘤病毒
疾病
免疫学
疾病负担
癌症
重症监护医学
妇科
内科学
作者
Kelsey Petrie,Alex Wells,Linda O. Eckert
标识
DOI:10.1016/j.ogc.2023.02.006
摘要
Cervical cancer is the fourth most common cancer in women worldwide with immense associated morbidity and mortality. Although most of the cervical cancer cases are caused by the human papillomavirus (HPV) and can effectively be prevented by HPV vaccination, vaccination unfortunately remains underused on a global scale with vast inequities in distribution. A vaccine as a tool to prevent cancer, cervical and others, is largely unprecedented. Then why do HPV vaccination rates globally remain so low? This article explores the burden of disease, development of the vaccine and its subsequent uptake, cost-effectiveness, and associated equity issues.
科研通智能强力驱动
Strongly Powered by AbleSci AI